Invasive zygomycosis in India: experience in a tertiary care hospital
- 1 November 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 85 (1009), 573-581
- https://doi.org/10.1136/pgmj.2008.076463
Abstract
Aim: To report the natural history and clinical course of zygomycosis from a single tertiary care centre in India where doctors maintain an institutional zygomycosis registry. Methods: The clinical and laboratory data collected prospectively from patients with antemortem diagnosis for invasive zygomycosis, and retrospectively from autopsy diagnosed cases, over an 18 month period (July 2006–December 2007) were combined and analysed. Results: During the period 75 cases (50 cases/year) of zygomycosis were reported. Antemortem diagnosis could be made in 81% of cases and 9% of patients had nosocomial zygomycosis. The spectrum of disease included rhino-orbito-cerebral (48%), pulmonary (17%), gastrointestinal (13%), cutaneous (11%), renal and disseminated zygomycosis (5% each). Uncontrolled type 2 diabetes (58%) and diabetic ketoacidosis (38%) in the rhino-orbito-cerebral type, renal failure (69%) in the pulmonary type, prematurity (70%) in the gastrointestinal type, and breach of skin (88%) in cutaneous zygomycosis, were the significant (pRhizopus oryzae (69%) was the most common isolate followed by Apophysomyces elegans (19%). Overall mortality was 45% in patients who could be treated. Outcome was significantly poor when surgical debridement could not be performed or the patients were treated only with amphotericin B deoxycholate. On multivariate analysis, patients with a Glasgow Coma Score (GCS) ⩾9 had a better prognosis. Conclusions: Zygomycosis is a threat in uncontrolled diabetes. New risk factors such as renal failure and chronic liver disease require attention. A elegans is an emerging agent in India. The need for surgical debridement in addition to medical treatment is emphasised. GCS is an independent marker of prognosis in cases of invasive zygomycosis.This publication has 31 references indexed in Scilit:
- Recommendations for the treatment of established fungal infectionsInternal Medicine Journal, 2008
- Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patientsIntensive Care Medicine, 2007
- Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and ManagementClinical Microbiology Reviews, 2005
- Mucormycosis: Ten-Year Experience at a Tertiary-Care Center in GreeceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Apophysomyces elegans : an Emerging Zygomycete in IndiaJournal of Clinical Microbiology, 2003
- Mucormycosis: Emerging Prominence of Cutaneous InfectionsClinical Infectious Diseases, 1994
- Rhinocerebral mucormycosis: Changing patterns of diseaseSurgical Neurology, 1994
- Disseminated Neonatal Gastrointestinal Mucormycosis: A Case Report and Review of the LiteraturePediatric Pathology, 1994
- Surveillance of nosocomial fungal infections in a burn care unitInfection, 1992
- Improved Diagnosis and Prognosis of MucormyucosisMedicine, 1986